Solide tumoren, fase I, MET, MET kinase inhibitor
T4N0 / st. III resectabel coloncarcinoom, fase 3, dMMR/MSI-H; Perioperatief Dostarlimab monotherapie versus SOC
Adenocarcinoom slokdarm maag, fase II, HER2-, F-doublets (F-Nal-IRI, CapCar and CapOx),
Rectumcarcinoom, fase III, clear resection margin (R0 resection)
dMMR oesofagogastrisch carcinoom, fase II, HER-2negatief, MSI positief
mCRC, observationeel, biopt
CROSS neoadjuvante chemoradiotherapie, fase II, actieve surveillance, nivolumab
Oesofaguscarcinoom, fase III, operabel HER2-positief
Solide tumoren, fase I, 2e lijn, selectieve WEE1 remmer (+carboplatine)
Solide tumoren, fase I, NRG1 fusiegen, antibody HER2/3
